-+ 0.00%
-+ 0.00%
-+ 0.00%

AFRRI/NIAID DESIGNS PROPRIETARY PBI-BM2.5 PROTOCOL TO EVALUATE VALION BIO'S (NASDAQ: VBIO) ENTOLIMOD AS THE FIRST AND ONLY TREATMENT FOR GI-ARS

Reuters·06/25/2026 11:45:18

Please log in to view news